budesonide inhalation

FDA Drug Profile — budesonide inhalation

Drug Details

Generic Name
budesonide inhalation
Brand Names
budesonide inhalation
Application Number
ANDA210897
Sponsor
A-S Medication Solutions
NDC Codes
3
Dosage Forms
SUSPENSION
Routes
RESPIRATORY (INHALATION)
Active Ingredients
BUDESONIDE

Indications and Usage

1 INDICATIONS AND USAGE Budesonide inhalation suspension is an inhaled corticosteroid indicated for: Maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age ( 1 ) Limitations of Use: Not indicated for the relief of acute bronchospasm ( 1 ) 1.1 Maintenance Treatment of Asthma Budesonide inhalation suspension is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age. Limitations of Use: Budesonide inhalation suspension is NOT indicated for the relief of acute bronchospasm.